MEX3B and chronic rhinosinusitis with nasal polyps: Our findings have the potential to lead to the development of therapeutic strategies targeting MEX3B, such as an antisense oligo targeting MEX3B, in the hope of improving clinical outcomes for patients with CRSwNP in the future.